| Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment S Shaikh, J Fatima, S Shakil, SMD Rizvi, MA Kamal Saudi journal of biological sciences 22 (1), 90-101, 2015 | 548 | 2015 |
| A simple click by click protocol to perform docking: AutoDock 4.2 made easy for non-bioinformaticians SMD Rizvi, S Shakil, M Haneef Excli Journal 12, 831, 2013 | 135 | 2013 |
| Mechanistic insights into the antimicrobial actions of metallic nanoparticles and their implications for multidrug resistance S Shaikh, N Nazam, SMD Rizvi, K Ahmad, MH Baig, EJ Lee, I Choi International journal of molecular sciences 20 (10), 2468, 2019 | 59 | 2019 |
| Prevalence of multidrug resistant and extended spectrum beta-lactamase producing Pseudomonas aeruginosa in a tertiary care hospital S Shaikh, J Fatima, S Shakil, SMD Rizvi, MA Kamal Saudi journal of biological sciences 22 (1), 62-64, 2015 | 46 | 2015 |
| Risk factors for acquisition of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae in North-Indian hospitals S Shaikh, J Fatima, S Shakil, SMD Rizvi, MA Kamal Saudi Journal of Biological Sciences 22 (1), 37-41, 2015 | 42 | 2015 |
| Current acetylcholinesterase-inhibitors: A neuroinformatics perspective S Shaikh, A Verma, S Siddiqui, S S Ahmad, S MD Rizvi, S Shakil, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 33 | 2014 |
| Invokana (Canagliflozin) as a dual inhibitor of Acetylcholinesterase and Sodium Glucose Co-Transporter 2: advancement in Alzheimer’s Disease-Diabetes Type 2 linkage via an … S MD Rizvi, S Shakil, D Biswas, S Shakil, S Shaikh, P Bagga, M A Kamal CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 31 | 2014 |
| In-vitro antibacterial and antioxidant potential of leaf and flower extracts of Vernonia cinerea and their phytochemical constituents SMD Rizvi, D Biswas, JM Arif, M Zeeshan International Journal of Pharmaceutical Sciences Review and Research 9 (2 …, 2011 | 31 | 2011 |
| Isolation, partial purification and evaluation of bioactive compounds from leaves of Ageratum houstonianum M Zeeshan, SMD Rizvi, MS Khan, A Kumar Excli Journal 11, 78, 2012 | 27 | 2012 |
| Multiple targets for the management of Alzheimer’s disease S Sayeed Ahmad, S Akhtar, Q Mohammad Sajid Jamal, M A Kamal, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2016 | 26 | 2016 |
| Forxiga (dapagliflozin): Plausible role in the treatment of diabetes‐associated neurological disorders S Shaikh, SMD Rizvi, S Shakil, S Riyaz, D Biswas, R Jahan Biotechnology and applied biochemistry 63 (1), 145-150, 2016 | 26 | 2016 |
| A novel process for size controlled biosynthesis of gold nanoparticles using bromelain S Khan, SMD Rizvi, M Avaish, M Arshad, P Bagga, MS Khan Materials Letters 159, 373-376, 2015 | 22 | 2015 |
| Role of anti-diabetic drugs as therapeutic agents in Alzheimer's disease SMD Rizvi, S Shaikh, SMA Waseem, S Shakil, AM Abuzenadah, D Biswas, ... EXCLI journal 14, 684, 2015 | 21 | 2015 |
| Molecular interaction of human brain acetylcholinesterase with a natural inhibitor Huperzine-B: An Enzoinformatics approach A Alam, S Shaikh, S S Ahmad, M A Ansari, S Shakil, S MD Rizvi, S Shakil, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 19 | 2014 |
| Magnetic Nanoparticles: Properties, Synthesis and Biomedical Applications S Khan, SMD Rizvi, V Ahmad, M Hassan Baig, M Amjad Kamal, S Ahmad, ... Current drug metabolism 16 (8), 685-704, 2015 | 17 | 2015 |
| Magnetic Nanoparticles: Properties, Synthesis and Biomedical Applications KMS Khan S, Rizvi SM, Ahmad V, Baig MH, Kamal MA, Ahmad S, Rai M, Zafar ... Current Drug Metabolism 16 (8), 685-704, 2015 | 17 | 2015 |
| Synthesis and Characterization of Cefotaxime Conjugated Gold Nanoparticles and Their Use to Target Drug‐Resistant CTX‐M‐Producing Bacterial Pathogens S Shaikh, SMD Rizvi, S Shakil, T Hussain, TM Alshammari, W Ahmad, ... Journal of Cellular Biochemistry 118 (9), 2802-2808, 2017 | 16 | 2017 |
| Prediction of comparative inhibition efficiency for a novel natural ligand, galangin against human brain acetylcholinesterase, butyrylcholinesterase and 5-lipoxygenase: a … S Shaikh, S S Ahmad, M A Ansari, S Shakil, S MD Rizvi, S Shakil, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 16 | 2014 |
| Kinetics and Molecular Docking Study of an Anti-diabetic Drug Glimepiride as Acetylcholinesterase Inhibitor: Implication for Alzheimer’s Disease-Diabetes Dual … SMD Rizvi, S Shaikh, D Naaz, S Shakil, A Ahmad, M Haneef, ... Neurochemical research 41 (6), 1475-1482, 2016 | 15 | 2016 |
| Silver nanoparticles from leaf extract of Mentha piperita: eco-friendly synthesis and effect on acetylcholinesterase activity A Khatoon, F Khan, N Ahmad, S Shaikh, SMD Rizvi, S Shakil, ... Life sciences 209, 430-434, 2018 | 14 | 2018 |
